GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (FRA:49Z) » Definitions » Net Current Asset Value

BICO Group AB (FRA:49Z) Net Current Asset Value : €-0.48 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is BICO Group AB Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

BICO Group AB's net current asset value per share for the quarter that ended in Mar. 2025 was €-0.48.

The historical rank and industry rank for BICO Group AB's Net Current Asset Value or its related term are showing as below:

During the past 9 years, the highest Price-to-Net-Current-Asset-Value Ratio of BICO Group AB was 40.30. The lowest was 7.85. And the median was 17.51.

FRA:49Z's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.82
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

BICO Group AB Net Current Asset Value Historical Data

The historical data trend for BICO Group AB's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB Net Current Asset Value Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only 2.04 -0.51 -1.10 -1.20 -0.79

BICO Group AB Quarterly Data
Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.34 -1.29 -0.98 -0.79 -0.48

Competitive Comparison of BICO Group AB's Net Current Asset Value

For the Medical Devices subindustry, BICO Group AB's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where BICO Group AB's Price-to-Net-Current-Asset-Value falls into.


;
;

BICO Group AB Net Current Asset Value Calculation

BICO Group AB's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net Current Asset Value Per Share(A: Dec. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(161.207-215.221-1.965-0)/70.575
=-0.79

BICO Group AB's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2025 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(157.48-189.714-1.771-0)/70.575
=-0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BICO Group AB  (FRA:49Z) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


BICO Group AB Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of BICO Group AB's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB Business Description

Traded in Other Exchanges
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. The company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Group consists of three reporting segments: Bioprinting, Life Science Solutions, and Lab Automation. Bioprinting consists of CELLINK, MatTek, Visikol, and Advanced BioMatrix. Life Science Solutions consists of CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, and Cellenion. Lab Automation consists of Biosero.

BICO Group AB Headlines

No Headlines